Neuphoria Therapeutics Inc (NEUP) — Cash Flow Reinvestment Rate
Neuphoria Therapeutics Inc (NEUP) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $3.00 (capex $3.00 ) from operating cash flow of $73.57 Million. Explore NEUP capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Neuphoria Therapeutics Inc Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Neuphoria Therapeutics Inc across 2 annual periods. Also explore Neuphoria Therapeutics Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Neuphoria Therapeutics Inc (2015–2025)
Year-by-year capital reinvestment analysis for Neuphoria Therapeutics Inc. For live market cap and broader valuation context, see NEUP stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $77.23 Million | $0.00 | ▼ -100.0% |
| 2015 | 0.13x | $649.08K | $4.94 Million | $649.08K | — |